| Literature DB >> 29408689 |
Joseph R Leventhal1, Joshua Miller1, James M Mathew2, Sunil Kurian3, Anat R Tambur1, John Friedewald4, Jane Charrette1, Michael M Abecassis5.
Abstract
Kidney transplant recipients given donor hematopoietic stem cells from their HLA-identical living related donors have now been followed between 5 and 9½ years post-operatively. Recipients who were designated as tolerant (Tol) have remained so since the last report when the 5 year (biopsy associated) milestone was reached. There has been 1 mortality of a Tol patient, unrelated to the study protocol, while 5 (of 15) have remained Tol between 7 and 8½ years post-operatively. There has been continuing elevated T-regulatory (CD4+CD25HighCD127-FOXP3+) cells in PBMC previously reported on. Ten year renal transplant biopsies are tentatively planned.Entities:
Keywords: Genomic markers; HLA-identical renal transplants; T and B regulatory cells; Tolerance
Mesh:
Substances:
Year: 2018 PMID: 29408689 PMCID: PMC5924714 DOI: 10.1016/j.humimm.2018.01.010
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850